CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- 4 Open-market buy Director bought 18,400 shares at an average $0.62 ($11,442)
- 4 Option exercise Director acquired 1,970,443 shares (option exercise)
- 4 Open-market buy Director bought 19,044 shares at $0.60 ($11,398)
- 4 Open-market buy Director bought 1,185,872 shares at an average $0.56 ($666,222)
- 4 Grant or award Director acquired 178,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 2,424,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 778,200 shares (grant or award)
- 4 Grant or award President and CEO acquired 4,654,100 shares (grant or award)
- 4 Grant or award Director acquired 178,000 shares (grant or award)
- 4 Grant or award Director acquired 178,000 shares (grant or award)
- 4 Grant or award Director acquired 178,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 548,200 shares (grant or award)
- 4 Grant or award Director acquired 178,000 shares (grant or award)
- 4 Grant or award Director acquired 178,000 shares (grant or award)
- 4 Grant or award Director acquired 178,000 shares (grant or award)
- 4 Grant or award Director acquired 178,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 1,531,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Returned to the company President and CEO returned 521,125 shares (to the company)
Page 5 of 21 · 410 filings